APOA1 and lung cancer: APOA1 has been shown to reduce lung cancer through its immunomodulatory mechanisms and anti-inflammatory characteristics by inhibiting the neo-angiogenesis of lung tumors while also reducing enzymes that enable cancer metastasis [75,98].